|
|
Construction and Phenotypic Analyses of Recombinant Lactobacillus Expressing Single-Chain Antibody of HIV |
AN Ming-hui1,2,3,TIAN Wen1,2,3,HAN Xiao-xu1,2,3,SHANG Hong1,2,3,** |
1 NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical University, Shenyang 110001, China 2 Key Laboratory of AIDS Immunology of Liaoning Province,The First Affiliated Hospital of China Medical University, Shenyang 110001, China 3 Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang 110001, China |
|
|
Abstract Recently, although the passive immunization strategy based on antibody drugs has achieved certain results in the prevention and treatment of HIV, supplement of antibodies is necessary to maintain its long-term effective concentration. The key question is how to prolong the active time of antibodies. Due to the food safety and mucosal colonization stability of lactobacillus, the anti-HIV single-chain antibody fragments were inserted in its expression plasmid with homologous promotor and signal peptide, and plasmid was transformed into competent cells of WCFS1 strains by electroporation. Positive single colonies were screened out by erythromycin, and after culture, the anti-HIV single-chain antibodies were detected to be expressed in the bacterial supernatant and the surpernatant can inhibit the HIV pseudovirus. Compared with the wild-type WCFS1 strain, the growth capacity of the recombinant strain in vitro did not changed and the CFU of the bacterial solution could reach to10 9/ml after 24 hours’ fermentation; the colonization ability of the recombinant strain also did not change obviously, and the each square centimeter of monolayer epithelial cells could bind 10 5CFU colonies. Expressing anti-viral proteins via a live recombinant lactobacillus as host rectal mucosal colonizers gave a new proposal to prevent HIV homosexual transmission.
|
Received: 14 March 2019
Published: 12 November 2019
|
|
Corresponding Authors:
Hong SHANG
|
|
|
[1] |
Gunthard H F, Aberg J A, Eron J J , et al. Antiretroviral treatment of adult HIV infection:2014 recommendations of the international antiviral society-USA panel. JAMA, 2014,312(4):410-425.
|
|
|
[2] |
Siliciano J D, Siliciano R F . Recent developments in the effort to cure HIV infection: going beyond N=1. J Clin Invest, 2016,126(2):409-414.
|
|
|
[3] |
Trovato M , D’Apice L,Prisco A,et al.HIV vaccination:a roadmap among advancements and concerns. Int J Mol Sci, 2018,19(4):1241.
|
|
|
[4] |
Sahay B, Nguyen C Q, Yamamoto J K . Conserved HIV epitopes for an effective HIV vaccine. J Clin Cell Immunol, 2017,8(4):518.
|
|
|
[5] |
Saunders K O, Pegu A, Georgiev I S , et al. Sustained delivery of a broadly neutralizing antibody in nonhuman primates confers long-term protection against simian/human immunodeficiency virus infection. J Virol, 2015,89(11):5895-5903.
|
|
|
[6] |
Caskey M, Klein F, Lorenzi J C , et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature, 2015,522(7557):487-491.
|
|
|
[7] |
Beyrer C , Baral S D,van Griensven F,et al.Global epidemiology of HIV infection in men who have sex with men. Lancet, 2012,380(9839):367-377.
doi: 10.1016/S0140-6736(12)60821-6
|
|
|
[8] |
Anbazhagan K, Sasikumar P, Gomathi S , et al. In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase. J Appl Microbiol, 2013,115(3):880-887.
|
|
|
[9] |
Mathiesen G, Sveen A, Piard J C , et al. Heterologous protein secretion by Lactobacillus plantarum using homologous signal peptides. J Appl Microbiol, 2008,105(1):215-226.
|
|
|
[10] |
Sasikumar P, Gomathi S, Anbazhagan K , et al. Genetically engineered lactobacillus plantarum WCFS1 constitutively secreting heterologous oxalate decarboxylase and degrading oxalate under in vitro. Curr Microbiol, 2014,69(5):708-715.
doi: 10.1007/s00284-014-0644-2
|
|
|
[11] |
Sasikumar P, Gomathi S, Anbazhagan K , et al. Secretion of biologically active heterologous oxalate decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 using homologous signal peptides. Biomed Res Int, 2013,2013:280432.
|
|
|
[12] |
Wu X, Guo J, Niu M , et al. Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. J Clin Invest, 2018,128(6):2239-2251.
|
|
|
[13] |
Ahrne S, Nobaek S, Jeppsson B , et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol, 1998,85(1):88-94.
|
|
|
[14] |
Nazzaro F, Fratianni F, Orlando P , et al. Biochemical traits,survival and biological properties of the probiotic Lactobacillus plantarum grown in the presence of prebiotic inulin and pectin as energy source. Pharmaceuticals (Basel), 2012,5(5):481-492.
|
|
|
[15] |
Kleerebezem M , Boekhorst J,van Kranenburg R,et al.Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci USA, 2003,100(4):1990-1995.
|
|
|
[16] |
Hols P, Slos P, Dutot P , et al. Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826. Microbiology, 1997,143(Pt8):2733-2741.
|
|
|
[17] |
王巧惠, 王光强, 宋馨 , 等. 不同质粒电转三种乳酸菌的比较研究. 工业微生物, 2016,46(1):36-41.
|
|
|
[17] |
Wang Q H, Wang G Q, Song X , et al. Comparative studies on electricity transformation of three kinds of lactic acid bacteria using different plasmids. Industrial Microbiology, 2016,46(1):36-41.
|
|
|
[18] |
Aukrust T W, Brurberg M B, Nes I F . Transformation of Lactobacillus by electroporation. Methods Mol Biol, 1995,47:201-208.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|